profile

Artenga’s breakthrough platform technology will serve serious unmet needs in cancer diagnosis and treatment.

Targeted microbubbles can replace multiple needle biopsies with a simple ultrasound scan for early diagnosis of microtumours.

Microbubbles and ultrasound can open up diseased cells and disrupt tumour blood flow to dramatically improve the effectiveness of drugs and other treatments.

Our microbubbles are optimized for diagnosis and therapy and we offer researchers an adjustable system.

Our technology has been placed in world-leading medical research institutions. In vivo testing has confirmed improved treatment compared to diagnostic microbubbles used as ultrasound contrast agents.

Artenga’s medical industry veterans have designed, manufactured, obtained regulatory approvals, and marketed devices to researchers and hospitals in many nations. We offer a ready to use microbubble solution and development support for custom applications.